[Correspondence] GRECCAR2 trial: details worthy of more attention

We read with great interest the GRECCAR 2 trial by Eric Rullier and colleagues (July 29, 2017, p 469),1 which reported that local excision showed no superiority over total mesorectal excision in rectal cancer patients with a good response after chemoradiotherapy. However, some aspects of the study warrant closer attention.
Source: LANCET - Category: General Medicine Authors: Tags: Correspondence Source Type: research